A phase II clinical trial of drug withdrawal in women with progressive breast cancer while on aromatase inhibitor therapy.

被引：5
|
作者：
Cigler, T.
Higgins, M. J.
Szymonifka, J.
Partridge, A. H.
Ligibel, J. A.
Finkelstein, D.
Come, S. E.
Ryan, P. D.
Goss, P. E.
机构：
[1] Weill Cornell Med Coll, New York, NY USA
[2] Massachusetts Gen Hosp, Boston, MA 02114 USA
[3] Dana Farber Canc Inst, Boston, MA 02115 USA
[4] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.559
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
559
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Drug withdrawal in women with progressive metastatic breast cancer while on aromatase inhibitor therapy
    Chavarri-Guerra, Y.
    Higgins, M. J.
    Szymonifka, J.
    Cigler, T.
    Liedke, P.
    Partridge, A.
    Ligibel, J.
    Come, S. E.
    Finkelstein, D.
    Ryan, P. D.
    Goss, P. E.
    [J]. BRITISH JOURNAL OF CANCER, 2014, 111 (11) : 2046 - 2050
  • [2] Drug withdrawal in women with progressive metastatic breast cancer while on aromatase inhibitor therapy
    Y Chavarri-Guerra
    M J Higgins
    J Szymonifka
    T Cigler
    P Liedke
    A Partridge
    J Ligibel
    S E Come
    D Finkelstein
    P D Ryan
    P E Goss
    [J]. British Journal of Cancer, 2014, 111 : 2046 - 2050
  • [3] A Phase II Clinical Trial of an Aromatase Inhibitor for Postmenopausal Women with Lymphangioleiomyomatosis
    Lu, Calvin
    Lee, Hye-Seung
    Pappas, George P.
    Dilling, Daniel F.
    Burger, Charles D.
    Shifren, Adrian
    Veeraraghavan, Srihari
    Chapman, Jeffrey T.
    Parambil, Joseph
    Ruoss, Stephen J.
    Young, Lisa R.
    Hammes, Stephen R.
    Kopras, Elizabeth J.
    Roads, Tammy
    Krischer, Jeffrey P.
    McCormack, Francis X.
    [J]. ANNALS OF THE AMERICAN THORACIC SOCIETY, 2017, 14 (06) : 919 - 928
  • [4] Bisphosphonate use in women with breast cancer on aromatase inhibitor therapy
    McGowan, A.
    van der Kamp, S.
    McKenna, M. J.
    [J]. IRISH JOURNAL OF MEDICAL SCIENCE, 2014, 183 : S463 - S463
  • [5] Evaluation of fulvestrant in women with advanced breast cancer and progression on prior aromatase inhibitor therapy: a phase II trial of the North Central Cancer Treatment Group.
    Ingle, JN
    Rowland, KM
    Suman, VJ
    Mirchandani, D
    Bernath, AM
    Camoriano, JK
    Perez, EA
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S38 - S38
  • [6] Activity of megestrol acetate in postmenopausal women with advanced breast cancer after nonsteroidal aromatase inhibitor failure: a phase II trial
    Bines, J.
    Dienstmann, R.
    Obadia, R. M.
    Branco, L. G. P.
    Quintella, D. C.
    Castro, T. M.
    Camacho, P. G.
    Soares, F. A.
    Costa, M. E. F.
    [J]. ANNALS OF ONCOLOGY, 2014, 25 (04) : 831 - 836
  • [7] A phase II trial of low dose estradiol in postmenopausal women with advanced breast cancer and acquired resistance to an aromatase inhibitor.
    Howell, S. J.
    Self, M. W.
    Armstrong, A. C.
    Cope, J.
    Wilson, G.
    Welch, R. S.
    Misra, V.
    Ryder, D.
    Blowers, E.
    Palmieri, C.
    Wardley, A. M.
    [J]. CANCER RESEARCH, 2012, 72
  • [8] Whole genome sequencing and analysis in a clinical trial setting: Aromatase inhibitor therapy in breast cancer
    Mardis, Elaine
    [J]. CANCER RESEARCH, 2011, 71
  • [9] A phase I/II clinical trial of cisplatin, and raltitrexed in patients with metastatic breast cancer refractory to anthracycline therapy.
    Rapoport, B
    Mahomed, R
    Uys, A
    [J]. ANNALS OF ONCOLOGY, 2000, 11 : 34 - 34
  • [10] Progressive relaxation training in patients with breast cancer receiving aromatase inhibitor therapy-randomized controlled trial
    Bahcaci, Umut
    Uysal, Songul Atasavun
    Iyigun, Zeynep Erdogan
    Ordu, Cetin
    Soybir, Gursel Remzi
    Ozmen, Vahit
    [J]. PLOS ONE, 2024, 19 (04):
12345